Healthcare Industry News:  Misonix 

Devices Neurosurgery Distribution

 News Release - February 14, 2007

Misonix Expands International Distribution of Neuroaspirator Product Line into Eastern and Central Europe

Agreement Announced with NORTH MED for Distribution in Czech Republic and Slovak Republic

FARMINGDALE, N.Y.--(HSMN NewsFeed)--Misonix, Inc. (NASDAQ: MSON ), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced the international expansion of its ultrasonic neuroaspirator product line into Eastern and Central Europe. As part of this expansion, Misonix entered into a distribution agreement with NORTH MED spol. s.r.o. for the FS1000RF "Sonastar" Ultrasonic Surgical Aspirator system, one of the products available under the Company's Neuroaspirator line. NORTH MED, a distributor of and service company for medical devices and equipment, has been named the exclusive distributor for Misonix's FS1000RF Sonastar Ultrasonic Surgical Aspirator for both the Czech Republic and Slovak Republic. NORTH MED will be distributing the FS1000RF primarily into the neurosurgery markets of these nations.

The Sonastar allows surgeons to precisely remove both soft and hard tissue such as brain and spinal tumors, boney processes and liver tumors. The FS1000RF Ultrasonic Aspirator System is indicated for use in the fragmentation, emulsification and aspiration of soft and hard (i.e. bone) tissue in the following surgical specialties: Neurosurgery, General, Gynecological, Plastic and Reconstructive, Orthopedic, Urological, Thoracic, Thoracoscopic, Laparoscopic and Gastrointestinal Surgery.

As a leading global manufacturer of numerous ultrasonic medical devices, Misonix continuously applies its technological expertise to improve its products. Using the Sonastar, medical practitioners and patients alike will benefit from upgrades such as an integrated RF (radio frequency) cauterizing capability to accelerate healing and the single use OsteoSculpt bone shaving attachment.

"We are very encouraged by the progress being made both domestically and internationally to grow our Neuroaspirator product line," stated Michael A. McManus, Jr., President and CEO of Misonix. "Demonstrating our intent to expand in Europe, NORTH MED broadens our presence into Central and Eastern Europe, and complements an impressive list of international distributors that currently includes distribution into Italy, Greece, Turkey and Canada. These alliances enable us to efficiently accumulate market share and grow our revenues from an established product line that has recently shown resurgence due to our ongoing product development activities. We continue to pursue relationships with potential distributors in the global market for our line of ultrasonic neuroaspirator products."

NORTH MED, based in the Czech Republic, is a privately held distributor and service center for medical equipment, and was founded in 1991 by Petr Krejsa, President. NORTH MED is a leading Czech Republic distributor of products for Neurosurgery, Cardiology, Gynecology and Patient Monitoring devices. The company currently distributes products for some of the largest medical device manufacturers in the world, including Phillips, Integra and Agilent.

About Misonix:

Misonix, Inc. (NASDAQ: MSON ) designs, develops, manufactures, and markets medical, scientific, and industrial ultrasonic equipment, laboratory safety equipment, and air pollution control products. Misonix's ultrasonic platform is the basis for several innovative medical technologies. Misonix has a minority equity position in Focus Surgery, Inc. which uses high intensity focused ultrasound technology to destroy deep-seated cancerous tissues without affecting surrounding healthy tissue. Addressing a combined market estimated to be in excess of $3 billion annually, Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, uncertainties as a result of research and development, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

Source: Misonix

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.